Effect of a New Potent Acid Inhibitory Drug, Vonoprazan on Healing Rate of Peptic Ulcers

Effect of a New Potent Acid Inhibitory Drug, Vonoprazan on Healing Rate of Peptic Ulcers - Effect of Vonoprazan on Healing Rate of Peptic Ulcers

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030384

Enrollment

300

Registered

2017-12-20

Start date

2016-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peptic Ulcers

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients with peptic ulcers confirmed endoscopically

Exclusion criteria

Exclusion criteria: inpatient with another disease a patient with the disease which has the risk of peptic ulcer a patient who underwent GI tract operation before malignant ulcer ulcers located at duodenal 2nd portion a patient who were administrated vonoprazan 20mg before

Design outcomes

Primary

Measure	Time frame
to check the healing status of the peptic ulcers (gastric ulcer, 8 weeks after / duodenal ulcer, 6 weeks after)	—

Countries

Japan

Contacts

Public ContactShigeto Koizumi

Akita University Graduate School of Medicine Department of Gastroenterology

shigeto@doc.med.akita-u.ac.jp018-884-6104

Outcome results